Egyptian Journal of Dermatology and Venereology is a premier peer-reviewed journal dedicated to advancing the fields of dermatology and venereology. Published by Wolters Kluwer Medknow Publications, this journal provides a vital platform for researchers, clinicians, and healthcare professionals to share cutting-edge research, case studies, and reviews that contribute to the understanding and treatment of skin and sexually transmitted diseases. With an ISSN of 1110-6530 and an E-ISSN of 2314-7407, the journal ensures global accessibility and visibility of its content, fostered by its commitment to high-quality publications. Although it operates with restricted access, the Egyptian Journal of Dermatology and Venereology remains an essential resource for practitioners and academics alike, supporting the dissemination of knowledge and innovation in skin health. Situated in Mumbai, India, the journal reflects a diverse pool of contributions that enrich our understanding of dermatological practices and principles on an international scale.

Clinical and Experimental Medicine is a leading journal published by Springer-Verlag Italia SRL, dedicated to advancing the understanding of the intricate relationships between biomedical research and clinical applications. Since its inception in 2001, the journal has garnered an esteemed reputation, achieving Q1 quartile rankings in 2023 in both Biochemistry, Genetics and Molecular Biology (miscellaneous) and Medicine (miscellaneous), establishing itself as a key resource for researchers and practitioners alike. With an impactful contribution reflected in its Scopus rankings, particularly a #81/221 rank in the General Biochemistry, Genetics and Molecular Biology category, Clinical and Experimental Medicine serves as a rich platform for peer-reviewed articles that bridge theory and practice across diverse medical disciplines. The journal embraces Open Access options, broadening the accessibility of groundbreaking research to a global audience, thereby fostering collaboration and innovation. Located in Milan, Italy, it continually endeavors to enrich knowledge and share valuable insights essential for the advancement of health sciences.

The Journal of Mid-life Health, published by Wolters Kluwer Medknow Publications, serves as a crucial platform for researchers and practitioners focusing on the multifaceted aspects of health during middle age. With a commitment to open access since 2010, this journal ensures that valuable research is available to a broad audience, fostering scholarly discussion and innovation in the field. Its ISSN is 0976-7800 and E-ISSN 0976-7819, making it easily identifiable in academic databases. Currently rated in the Q3 quartile in both health (social science) and miscellaneous medicine categories for 2023, the journal is positioned among the top tier of its peers, reflecting its significance in these domains. The journal ranks #222 in the Medicine (miscellaneous) category and #223 in Social Sciences (health) according to Scopus, showcasing its impact and relevance in contemporary discourse around mid-life health challenges. Researchers, health professionals, and students alike can benefit from the journal’s comprehensive articles, which span a variety of topics essential for understanding and improving health outcomes in middle age.

The Journal of Dermatology, published by Wiley, is a premier academic journal dedicated to advancing the field of dermatology, with its esteemed reputation reflected in its Q1 ranking in Dermatology and a remarkable Q2 ranking in Miscellaneous Medicine as of 2023. Since its inception in 1974, the journal has become a vital resource for researchers, clinicians, and students alike, covering pioneering studies and cutting-edge advancements in skin health and disease. With a Scopus rank of #32 out of 142 in the Dermatology category, placing it in the 77th percentile, the journal underscores its commitment to fostering knowledge and innovation within the dermatological community. Although the journal operates under a subscription model, it remains an essential platform for disseminating impactful research that shapes clinical practice and enhances patient care. For anyone invested in dermatological sciences, Journal of Dermatology serves as a key publication where critical insights and developments are regularly showcased.

The Lancet Oncology is a premier peer-reviewed journal published by Elsevier Science Inc., recognized as a leading authority in the field of oncology. With an ISSN of 1470-2045 and E-ISSN 1474-5488, this esteemed journal boasts an impressive 2023 impact factor placing it in the Q1 category of oncology—reflecting its role as a critical resource for cutting-edge research. The journal publishes high-quality articles covering novel scientific discoveries, clinical advancements, and public health issues related to cancer treatment and prevention. It is ranked #5 out of 404 in the Scopus Medicine _ Oncology category, demonstrating its influence and relevance in the field, with an outstanding rank in the 98th percentile. Operating from its base in the United Kingdom, The Lancet Oncology spans a comprehensive timeframe from 2000 to 2024, making it a vital repository of oncology literature. Although it does not primarily operate on an open-access model, its significant subscription base ensures that a wealth of knowledge is accessible to researchers, professionals, and students alike, fostering a profound understanding and advancement in oncology.

CLINICAL OBSTETRICS AND GYNECOLOGY, published by LIPPINCOTT WILLIAMS & WILKINS, stands as a pivotal journal in the field of obstetrics and gynecology, boasting a rich history since its inception in 1958. With its ISSN 0009-9201 and E-ISSN 1532-5520, the journal serves as a critical repository of contemporary research and clinical advancements, providing invaluable insights to healthcare professionals and researchers. As a prominent Q2 ranked journal in the Obstetrics and Gynecology category, it is recognized for its impactful contributions to medical practice and education, holding a respectable Scopus rank of #103 out of 209, placing it in the 50th percentile. While not an open-access journal, it ensures wide dissemination of knowledge through institutional subscriptions, enhancing the accessibility of its peer-reviewed content. The scope of the journal encompasses a diverse range of topics vital to the ongoing evolution of women's health, making it an essential resource for those dedicated to fostering clinical excellence and advancing research in obstetrics and gynecology.

The Journal of Diabetology, published by Wolters Kluwer Medknow Publications, is a premier platform dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Since its inception in 2010, this Open Access journal has provided researchers and healthcare professionals with a wealth of knowledge through rigorous peer-reviewed articles that cover clinical research, epidemiology, and innovative treatment strategies. With an E-ISSN of 2078-7685 and a commitment to disseminating high-quality scientific work, the journal plays a pivotal role in contributing to the global discourse on diabetes care and prevention. Its dedication to accessibility enhances its impact on both established scholars and emerging researchers seeking to make meaningful contributions in the field. By fostering a collaborative environment, the Journal of Diabetology aims to bridge the gap between research and practical implementation, ultimately improving outcomes for individuals affected by diabetes.

The Journal of Egyptian Women's Dermatological Society, published by Wolters Kluwer Medknow Publications, is an essential platform dedicated to advancing the field of dermatology through a valuable focus on women's health issues. Established to provide an open access outlet since 2019, this journal aims to disseminate research, case studies, and reviews that address the unique dermatological needs and concerns of women, particularly in the Egyptian context. Despite its current ranking in the Q4 category in dermatology and a Scopus rank of #117 out of 142 with a 17th percentile, the journal serves a critical role in fostering scholarly communication among researchers, clinicians, and academicians. With a commitment to promoting knowledge advancement and community engagement, this journal invites submissions that align with its objectives, specifically geared towards empirical research and innovative practices in dermatology impacting women's health.

American Journal of Physical Medicine & Rehabilitation, published by Lippincott Williams & Wilkins, is a leading journal in the field of rehabilitation, dedicated to advancing knowledge in physical medicine and rehabilitation practices. With an established history from 1988 to 2024, this journal serves as a vital resource for clinicians, researchers, and students interested in the multifaceted aspects of rehabilitation science. It holds a commendable Q2 ranking in the Physical Therapy and Sports Therapy fields and a prestigious Q1 position in Rehabilitation, reflecting its impact and relevance in the academic community. The journal's Scopus rankings further highlight its significance, placing it among the top percentile for both rehabilitation medicine and physical therapy. Although it does not currently offer open access options, its accessibility through institutional subscriptions ensures widespread reach. By publishing high-quality research, clinical studies, and reviews, the American Journal of Physical Medicine & Rehabilitation plays a critical role in shaping contemporary rehabilitation practices and improving patient outcomes.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, published by Wiley, is a premier peer-reviewed journal dedicated to advancing the fields of dermatology and venereology. Since its inception in 1991, this esteemed journal has established itself as a vital resource, providing a platform for innovative research and critical analysis in these important medical disciplines. With an impressive Impact Factor stemming from its Q1 category ranks in both dermatology and infectious diseases, it has achieved a dominant position, ranking #4 out of 142 in Dermatology and #37 out of 344 in Infectious Diseases according to Scopus. Researchers and clinicians alike are encouraged to engage with the rich content and robust discussions presented in its pages, fostering collaboration and cutting-edge advancements in patient care. Access options to this journal can be explored through Wiley, allowing for widespread dissemination and engagement in the academic community. The journal’s ongoing commitment to excellence ensures its relevance and significance in shaping the future of dermatological and venereological research.